Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Adore Beauty strengthens presence in wellness circles with acquisition of clean beauty brand iKOU
    • News

    Adore Beauty strengthens presence in wellness circles with acquisition of clean beauty brand iKOU

    While many of us are on a constant lookout for a beauty routine that rejuvenates both beauty and wellness, some may wonder if this focus on aesthetics improves lifestyle or simply a passing trend? Adore Beauty (ASX: ABY), a leading Australian online beauty retailer, is betting on the former with a $25 million all-cash acquisition

    Read More
    Public
  • East 33 issues harvest downgrade as harsh rainfall impacts oyster production volumes
    • News

    East 33 issues harvest downgrade as harsh rainfall impacts oyster production volumes

    The pandemic may have been detrimental to humans but the oyster population was not immune, decimating aquaculture company East 33 (ASX: E33) which is still navigating the rocky seas of recovery based on their latest trading update.  August 2021 tested East 33 beyond their generational knowledge of harvesting oysters. The severe outbreak of an illness,

    Read More
    Public
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank
    • News

    Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank

    After changing its name, gaining adequate funding and being reinstated to the ASX, fintech and digital commerce company Ovanti (ASX: OVT), previously known as IOUPay (ASX: IOU), is finally returning to doing business after allegations of fraud and misappropriation of funds.  The Company has signed a major new contract through its subsidiary, iSentric (no affiliation

    Read More
    Public
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth
    • News

    Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth

    Australia sees about 300,000 births every year, creating a fertile ground for businesses like Baby Bunting (ASX: BBN) to thrive, but that hasn’t been the case in recent months as sales have reflected a big pullback in spending amid cost-of-living pressures on young families and online competition from the likes of Temu and Shein.  From

    Read More
    Public
  • XJO to fall on rate concerns
    • Market Update

    XJO to fall on rate concerns

    The XJO is expected to open lower this morning despite another small rise in the U.S overnight. We should open near 7,700 key support as our market continues to sell off. There are a few likely reasons for our extended sell down this morning. Firstly, U.S futures have moved into the red. Secondly, the financials

    Read More
    Public
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch
    • News

    CLEO meets with US FDA to develop strategy for ovarian cancer test launch

    Ovarian cancer diagnostics company Cleo Diagnostics (ASX: COV) has taken a major step towards the US launch of its pre-surgical triage test for ovarian cancer detection. The Company wrapped up an initial pre-submission meeting with the U.S. Food and Drug Administration (FDA), thus setting its regulatory journey in motion. Ovarian cancer is a serious health

    Read More
    Public
  • «
  • ‹
  • 61
  • 62
  • 63
  • 64
  • 65
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.